Cryptococcal Meningitis Screening and Community-based Early Adherence Support in People With Advanced Human Immunodeficiency Virus Infection Starting Antiretroviral Therapy in Tanzania and Zambia: A Cost-effectiveness Analysis

BACKGROUND: A randomized trial demonstrated that among people living with late-stage human immunodeficiency virus (HIV) infection initiating antiretroviral therapy, screening serum for cryptococcal antigen (CrAg) combined with adherence support reduced all-cause mortality by 28%, compared with stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimaro, Godfather Dickson, Guinness, Lorna, Shiri, Tinevimbo, Kivuyo, Sokoine, Chanda, Duncan, Bottomley, Christian, Chen, Tao, Kahwa, Amos, Hawkins, Neil, Mwaba, Peter, Mfinanga, Sayoki Godfrey, Harrison, Thomas S, Jaffar, Shabbar, Niessen, Louis W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146002/
https://www.ncbi.nlm.nih.gov/pubmed/31149704
http://dx.doi.org/10.1093/cid/ciz453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146002/
https://www.ncbi.nlm.nih.gov/pubmed/31149704
http://dx.doi.org/10.1093/cid/ciz453

Ejemplares similares